Navigation Links
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Date:10/5/2009

rs, hemorrhagic/ischemic colitis, dyspnea, pulmonary infiltrates, pneumonia, interstitial pneumonitis, pulmonary hypertension, hepatic failure, increases in serum creatinine in patients with renal insufficiency, acute hypersensitivity (angioedema, bronchoconstriction, anaphylaxis and cutaneous eruptions), hypertriglyceridemia, and peripheral neuropathy.

During the course of therapy lasting up to 48 weeks in patients ages 3 through 17 years receiving PEGINTRON/REBETOL combination therapy, weight loss and growth inhibition were common.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this media alert includes certain "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995, including statements relating to clinical development of investigational oncology compounds. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded,
'/>"/>

SOURCE Schering-Plough Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , ... July 28, 2015 , ... Women fear developing ... reason is that cancer, heart attack, and stroke are treatable, but there is little ... can do is to take part in a clinical trial, reports the July 2015 ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom ... cardiology is the identification of individuals with active yet undetected sub-clinical disease, who ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... for identifying Top Doctors, has based its selection process on the foundation of ... in their medical specialties, in any area of medicine and in any part ...
(Date:7/28/2015)... ... 2015 , ... One of the most common running related ... plantar fasciitis . Zensah, the Miami-based compression brand, offers a product that can ... the Zensah Ankle Support’s primary benefits include helping support the ankle, reduce swelling, ...
(Date:7/28/2015)... ... July 28, 2015 , ... Nurses across all settings ... up to 57 million Americans may need mental health services (SAMHSA, 2013) and the ... Psychiatric-mental health RNs are one of the largest workforces who provide care to ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 3Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 4
... A novel gene called rumi regulates Notch signaling by ... Notch protein that extends outside a cell, said researchers ... Brook University in New York in a report that ... governed by the Notch protein determines cell fate determination ...
... works for allergic asthma, rhinitis, conjunctivitis or insect ... If you have allergic asthma, rhinitis, conjunctivitis or ... candidate for allergy shots, also known as immunotherapy. ... of Allergy, Asthma & Immunology. , "Immunotherapy is ...
... MYL ),today announced that it intends to appeal ... for the District of Columbia against Mylan and its ... of the,pending Lorazepam and Clorazepate antitrust cases. The first ... disclosed, in June 2005, a jury in the district ...
... Society of Plastic Surgeons (ASPS) today addressed concerns,regarding ... events following,a recent petition from a consumer group., ... U.S. Food and Drug,Administration (FDA) implement labeling changes ... one million people have been treated with BOTOX ...
... Unland, President of the,Chicago-based Health Capital Group, urged hospitals, ... their existing debt instruments, their,obligations and their capital and ... Problems with some major banks and bond insurers have ... do so for some time to come,resulting in both ...
... no medical benefit; heart expert calls it ,second-line, ... The controversy surrounding the highly promoted cholesterol-lowering drug ... they would review the medication,s effectiveness, but only ... debate began earlier this month when preliminary results ...
Cached Medicine News:Health News:Notch-ing glucose into place 2Health News:Allergy Shots Are Effective Treatment for Symptoms 2Health News:Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2Health News:Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans 2Health News:FDA Will Wait for Trial Results on Vytorin 2Health News:FDA Will Wait for Trial Results on Vytorin 3
(Date:7/28/2015)... first virtual care solution to empower health care systems with ... care service line, announced an agreement with Group Health ... use. Logo ... As health systems consider how to keep ... their own branded online care for common medical conditions. As ...
(Date:7/28/2015)... DUBLIN , July 21, 2015 ... the addition of the "Pharmaceutical Industry in ... Multinational and Chinese Biopharma Companies, Industry Trends, Environment, ... report to their offering. This ... in China but also ...
(Date:7/28/2015)... , July 28, 2015  Alere Inc. (NYSE: ... announced that it will release its financial results for ... will host a conference call beginning at 8:30 a.m. ... results and provide business updates. The ... Relations section of Alere,s website, or accessed directly through ...
Breaking Medicine Technology:Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2
... AMSTERDAM, The Netherlands, June 30 ... Major Impact on the Decision-Making Process With,Respect to Infertility ... an economic analysis presented today at this year,s,European Society ... the parameters of the simulation model used, the in ...
... ROCHESTER, Minn., June 29 Pioneering therapeutic trials to ... in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette,s ... according to a review in the June 2009 issue of ... . "Deep brain stimulation has long been seen as valuable ...
Cached Medicine Technology:New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 2New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 3New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF 4Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 2Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases 3
... a high quality fiberoptic system designed to ... to fiberoptic laryngoscopes. The green color coding ... ability to interconnect with other green coded ... cool, bright and focused light. The Greenspec ...
... Lamp supplied with blade. Fiberoptic blades ... standard/conventional handle allowing you to take ... potential confusion from different fitting fiberoptic ... easy and cost effective alternative to ...
... used with Portex® reusable or disposable laryngoscope ... long-lasting bronze fiber-optic bundles provide the durability ... ,The laryngoscope blades are available in ... to large adult, and in all popular ...
... system. Providing an unobstructed view of the ... many types of intubations., ,A high ... patented Glidescope blade. Clear images are captured ... monitor screen. An LED light source mounted ...
Medicine Products: